GLUC NACL 2:1 Fresenius 1000ml Freeflex 10 pce

7680496851305 CH-49685 B05BB02 05.03.3.

Active substances:

No images available

Details

Product number
4968501
CPT
-
Packaging group
10 x 1000
Unit
ml
Composition
glucosum 33.3 g ut glucosum monohydricum, natrii chloridum 3 g corresp. natrium 51.3 mmol et chloridum 51.3 mmol, acidum hydrochloridum aut natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 1000 ml.

Articles (1)

Glucose 5%-NaCl 0,9% 2:1 Fresenius, Infusionslösung
Infusionslösung
10 x 1000
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
13/05/2025
Professional SmPC
Français
13/05/2025
Professional SmPC
Italien
13/05/2025

Detailed composition

Substance Quantity Type Category
glucosum
33.3 G Substance Wirkstoff (Principe actif)
glucosum monohydricum
- Substance WIZUS
natrii chloridum
3.0 G Substance Wirkstoff (Principe actif)
natrium
51.3 MMOL Substance WIIS
chloridum
51.3 MMOL Substance WIIS
acidum hydrochloridum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Authorization holder

Fresenius Kabi (Schweiz) AG

6010 Kriens

Authorization information

Swissmedic authorization number
49685
Drug name
Glucose 5%-NaCl 0,9% Fresenius, Infusionslösung
Galenic form
LSINF
ATC Code
B05BB02
Authorization status
Z
Dispensation category
B
First authorization
28/11/1988
Authorization expiration date
31/12/9999
IT number
05.03.3.
Domain
Human medicine
Field of application
Dehydratation, Oligurie

Packaging details

Description (FR)
GLUC NACL 2:1 Fresenius 1000ml Freeflex 10 pce
Description (DE)
GLUC NACL 2:1 Fresenius 1000ml Freeflex 10 Stk
Market launch
28/11/1988
Narcotic (BTM)
No

Other packaging sizes

GLUCOSE NACL 2:1 Fresenius 500ml Freeflex 20 pce
20 x 500 ML
View
GLUC NACL 2:1 Fresenius 250ml KabiPac
20 x 250 ML
View
GLUC NACL 2:1 Fresenius 500ml KabiPac 10 pce
10 x 500 ML
View
GLUCOSE NACL 2:1 Fresenius 1000ml KabiPac 10 pce
10 x 1000 ML
View
Buy us a coffee Explore the data